Laura V.

Laura V. is a Senior Global Pharmacovigilance Leader with extensive experience in clinical risk management and safety evaluation across various therapeutic areas, including oncology and neurology. They have held prominent roles at organizations such as BeOne Medicines, Organon, and Merck, where they excelled in developing safety strategies, leading teams, and ensuring compliance with regulatory standards. Currently, Laura V. serves as Sr. Director of Drug Safety and Pharmacovigilance at BridgeBio. They are pursuing a Bachelor of Science in Critical Care Nursing from the University of Delaware and a Master of Science in Healthcare Administration from Saint Mary's College of California.